On the other hand, we did not find compelling evidence for SMAD1 downregulation in prostate cancer; rather, SMAD1 mRNA levels may even be upregulated in prostate carcinomas (Supplementary Fig. S7). This evidence concerns the gene SMAD1 and prostate carcinoma.